Home » Venture Capital » Current Portfolio

Current Portfolio

Flagship invests in three principle business sectors: Therapeutics; Medical Technologies; and Sustainability/Clean Technology. Initial investments range between $250 thousand and $5 million, and we may invest up to $12-15 million during the life of a company. Click on a tab below to filter the listing of the portfolio by industry sector, or on a column heading to sort.

Company Description Status Initial Datesort icon
<a href="/venture-capital/all-companies/blend-therapeutics-inc">Blend Therapeutics Inc.</a> Pioneering controlled combination medicines that overcome the limitations of conventional combination therapy. Private 2012 View Profile
<a href="/venture-capital/all-companies/permeon-biologics-inc">Permeon Biologics Inc.</a> Developing unprecedented intracellular biotherapeutics. Private 2011 View Profile
<a href="/venture-capital/all-companies/breathable-foods-inc">Breathable Foods Inc.</a> Pioneering novel devices and formulations for the delivery of nutrients and pharmaceuticals through the act of breathing. Private 2011 View Profile
<a href="/venture-capital/all-companies/tangent-medical-technologies-inc">Tangent Medical Technologies Inc.</a> Tangent Medical Technologies is advancing infusion therapy by improving catheter stability, patient comfort and healthcare worker safety with its proprietary, intravenous catheters and associated products. Private 2011 View Profile
<a href="/venture-capital/all-companies/transmedics-inc">TransMedics, Inc.</a> Developed the first commercial, portable warm blood perfusion system that allows for a new type of organ transplant. Private 2010 View Profile
<a href="/venture-capital/all-companies/moderna">ModeRNA</a> Commercializing a new class of RNA-based drugs. Private 2010 View Profile
<a href="/venture-capital/all-companies/medidametrics-inc">MedidaMETRICS, Inc.</a> Dedicated to improving healthcare performance and clinical quality Private 2010 View Profile
<a href="/venture-capital/all-companies/essentient">Essentient</a> Transforming global nutrition. Private 2010 View Profile
<a href="/venture-capital/all-companies/midori-renewables-inc">Midori Renewables Inc.</a> Commercializing chemical catalysts for upgrading waste biomass to fuels, chemicals, and materials. Private 2010 View Profile
<a href="/venture-capital/all-companies/advanced-electron-beams-inc">Advanced Electron Beams, Inc</a> Utilizing highly efficient electron beams for sterilization, curing, polymer treatment and pollution abatement. Private 2009 View Profile
<a href="/venture-capital/all-companies/avedro-inc">Avedro, Inc.</a> Developing incisionless vision correction procedures. Private 2009 View Profile
<a href="/venture-capital/all-companies/celexion-llc">Celexion LLC</a> Developing powerful synthetic biology tools for engineering biotherapeutics. Private 2009 View Profile
<a href="/venture-capital/all-companies/oasys-water-inc">Oasys Water, Inc.</a> Developing a suite of proprietary energy and resource recovery products to address the growing, global water crisis. Private 2009 View Profile
<a href="/venture-capital/all-companies/receptos-inc">Receptos, Inc.</a> Utilizing pioneering G-protein coupled receptor technology to facilitate information-driven drug design. Private 2009 View Profile
<a href="/venture-capital/all-companies/selecta-biosciences-inc">Selecta Biosciences, Inc.</a> Developing a new class of synthetic nanoparticle vaccines. Private 2008 View Profile
<a href="/venture-capital/all-companies/accuri-cytometers-inc">Accuri Cytometers, Inc.</a> Developing and manufacturing revolutionary, low-cost, high-performance flow cytometers for researchers. Acquired 2008 View Profile
<a href="/venture-capital/all-companies/theracrine">Theracrine</a> Developing anti-metastatic drugs as a new category of cancer therapeutics. Private 2008 View Profile
<a href="/venture-capital/all-companies/taris-biomedical-inc">TARIS Biomedical, Inc.</a> Developing local minimally-invasive drug-device convergence products. Private 2008 View Profile
<a href="/venture-capital/all-companies/eleven-biotherapeutics-inc">Eleven Biotherapeutics, Inc.</a> Engineering and developing innovative protein-based therapeutics. Private 2008 View Profile
<a href="/venture-capital/all-companies/visterra-inc">Visterra, Inc.</a> Discovering and developing innovative products that will transform the prevention and treatment of infectious diseases. Private 2008 View Profile